<https://rdf.molmedb.upol.cz/reference/ref3847> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00085>,
		<https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM00507>,
		<https://identifiers.org/molmedb/MM493551>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2016.05.054"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/pmid> "27241692"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/bibliographicCitation> "Gurrapu S, Jonnalagadda SK, Jonnalagadda SK, Alam MA, Ronayne CT, Nelson GL, Solano LN, Lueth EA, Drewes LR, Mereddy VR.: Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents. Bioorg Med Chem Lett, Volume 26 (14), 2016"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21> .
<https://rdf.molmedb.upol.cz/interaction/int1030581> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3847> .
<https://rdf.molmedb.upol.cz/interaction/int1028549> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3847> .
<https://rdf.molmedb.upol.cz/interaction/int1027485> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3847> .
<https://rdf.molmedb.upol.cz/interaction/int1030582> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3847> .
<https://rdf.molmedb.upol.cz/interaction/int1027484> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3847> .
<https://rdf.molmedb.upol.cz/interaction/int1028550> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3847> .